Advertisement

Biden’s New HIV/AIDS Strategy Calls Racism a Roadblock to Victory

0

Strategy outlines the direction of the White House's policies, research, programs, and planning for the next three years

Many Hospitals Lack All-Trans Retinoic Acid for Treating Leukemia

0

Only 14 percent of hospitals that referred patients with acute promyelocytic leukemia had ATRA readily available

Most Immunosuppressive Meds Not Tied to Worse COVID-19 Outcomes

0

Except for rituximab, no increased risk seen for in-hospital death or mechanical ventilation for those on long-term immunosuppressive therapy

Concurrent Zoster, Flu Vaccines Tied to Lower Subsequent Flu Vaccine Uptake

0

Patients may misattribute adverse effects commonly caused by the zoster vaccine to the influenza vaccine

First U.S. Omicron Case Reported in California

0

Patient was a traveler, apparently from the San Francisco area, who returned from South Africa on Nov. 22

First Overdose Prevention Centers in the Nation Open in NYC

0

Cities and states nationwide have pushed for overdose prevention sites in recent years

Giving Nivolumab/Ipilimumab First Ups Overall Survival in Melanoma

0

Two-year overall survival 72 percent for those starting with N/I, 52 percent for those starting with dabrafenib/trametinib

Colchicine No Benefit Over Supportive Care for COVID-19

0

No significant reduction reported in mortality, ventilatory support, ICU admission, length of stay, serious adverse events; increase seen in adverse events, diarrhea

AAV Gene Transfer Feasible for the Treatment of Hemophilia A

0

In a phase 1-2 trial, 16 of 18 men had sustained expression of factor VIII after gene transfer with adeno-associated viral vector (SPK-8011)

ATS: Consider FEɴᴏ Test for Optimizing Asthma Treatment

0

The use of FENO testing in addition to usual care is suggested for patients with asthma in whom treatment is being considered